FdaApplication
ANDA 212260
Identifiers
- fda_app_no: ANDA212260
Properties
| Property | Value |
|---|---|
| applicant_name | NOVITIUM PHARMA LLC |
| application_type | ANDA |
| approval_date | 2019-05-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 10MG BASE/ML | FOR SUSPENSION;ORAL |
1 product